CELL INTELLIGENCE · 肿瘤细胞治疗研究

甲状腺癌中基于 NK 细胞和细胞外囊泡的免疫治疗：进展、挑战与未来展望

Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives.

NK 细胞来源外泌体模拟物作为天然纳米载体用于体外向甲状腺癌细胞递送化疗药物

Natural Killer Cell-Derived Exosome Mimetics as Natural Nanocarriers for In Vitro Delivery of Chemotherapeutics to Thyroid Cancer Cells.

负载索拉非尼的 NKEM 在体外显示出杀伤甲状腺癌细胞的能力，甚至对 ATC 也有效。这为药物递送系统和甲状腺癌治疗提供了新机会。

探索人未成熟牙髓细胞来源细胞外囊泡对甲状腺乳头状癌的治疗潜力

Exploring the Therapeutic Potential of Extracellular Vesicles Derived from Human Immature Dental Pulp Cells on Papillary Thyroid Cancer.

间充质干细胞来源细胞外囊泡携带的 GTF2I 促进抑瘤性 FAT1 表达并抑制甲状腺癌干性维持

Extracellular vesicle-carried GTF2I from mesenchymal stem cells promotes the expression of tumor-suppressive FAT1 and inhibits stemness maintenance in

靶向白细胞介素-4 受体的肽修饰细胞外囊泡作为甲状腺癌体内药物递送平台

Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer.